Nevro Corp.
NYSE:NVRO
3.79 (USD) • At close December 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Nevro Corp. |
Symbool | NVRO |
Munteenheid | USD |
Prijs | 3.79 |
Beurswaarde | 142,017,364 |
Dividendpercentage | 0% |
52-weken bereik | 3.52 - 22.525 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Kevin R. Thornal |
Website | https://www.nevro.com |
An error occurred while fetching data.
Over Nevro Corp.
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)